Pharmacokinetics of ASP3662
1 clinical trials · Condition
◉ Watch Pharmacokinetics of ASP3662
| Record | Firm | Date |
|---|---|---|
| A Positron Emission Tomography Occupancy Study Using Ligand [11C]AS2471907 and Following Oral Dosing of ASP3662 (NCT02194491) | Astellas Pharma Global Development, Inc. | 2014-04-01 |
Track Pharmacokinetics of ASP3662 automatically
Every clearance here is in the API, with alerts when new ones post.